EP3284754
And-CD38 mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
30.12.2011EP published:
4.11.2020EP application number:
17189925.5
EP translation filed:
17.12.2020Grant published:
15.1.2021EPO information:
European Patent Register
Max expiry date:
29.12.2031Expiry date:
29.12.2026Next due date:
31.12.2026
Title:
ANTI-CD38 ANTIBODIES
Timeline
Today
30.12.2011EP application
4.11.2020EP Publication
17.12.2020Translation submitted
15.1.2021Registration published
29.12.2026Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
Inventor
Name:
ELIAS, Kathleen AnnAddress:
San Diego, CA 92121, US
Name:
LANDES, GregoryAddress:
San Diego, CA 92121, US
Name:
SINGH, ShwetaAddress:
San Diego, CA 92121, US
Name:
KORVER, WouterAddress:
San Diego, CA 92121, US
Name:
DRAKE, Andrew WallingAddress:
San Diego, CA 92121, US
Name:
HAAK-FRENDSCHO, MaryAddress:
San Diego, CA 92121, US
Name:
SNELL, Gyorgy PalAddress:
San Diego, CA 92121, US
Name:
BHASKAR, VinayAddress:
San Diego, CA 92121, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201061428699 PDate:
30.12.2010Country:
US
Number:
201161470406 PDate:
31.3.2011Country:
US
Number:
201161470382 PDate:
31.3.2011Country:
US
Number:
201161485104 PDate:
11.5.2011Country:
US
Classification
Categories:
C07K 16/28, A61P 35/02
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 19.1.2021
Expires: 29.12.2021
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 17.11.2021
Expires: 29.12.2022
Payer: Patice ehf.
Number: 12
Paid: 22.11.2022
Expires: 29.12.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.12.2023
Expires: 29.12.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 28.11.2024
Expires: 29.12.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 19.12.2025
Expires: 29.12.2026
Payer: Árnason Faktor ehf.